ARCHIVES

NCI Director Declines To Fund P-4 Breast Cancer Chemoprevention Trial.

This article is from The Cancer Letter archive.

Vol. 33 No. 24 | June 22, 2007

Download PDF Visit The Full Archive

Related Articles

Caution Advised for Hormone Replacement Therapy

March 21, 1986

NEJM Says Henschke Conflicts Irrelevant; Propriety Of Granting CME Questioned.

March 14, 2008

ACS Endorses Clinton Health Care Reform, Wit qualifications

March 11, 1994

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

January 27, 2006

Breast Cancer Task Force Suggests 12 New Projects For RFPs, Hears Report On Hormones

January 16, 1976

NRC Group Splits Over chemical Dose Testing For Carcinogenicity

March 12, 1993